HSPA5 and central nervous system cancer: We transfected HSPA5 siRNA into LIMD1-AS1-overexpressed SF126 glioma cells and found that knockdown of HSPA5 expression significantly reduced LIMD1-AS1-induced increase IFN signatures mRNA levels in SF126 glioma cells (Fig. 9I).